CTOs on the Move

OraSure

www.orasure.com

 
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure`s portfolio of products is sold globally to clinical laboratories, hospitals, physician`s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.orasure.com
  • 220 East First Street
    Bethlehem, PA USA 18015
  • Phone: 610.882.1820

Executives

Name Title Contact Details

Similar Companies

Rigid Medical Technologies Inc

Rigid Medical Technologies Inc is a Austin, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Plantex USA

Plantex USA is a Woodcliff Lake, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

LKC Technologies

LKC Technologies is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vapotherm, Inc.

Vapotherm, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Cvrx

CVRx® is a private company located in Minneapolis, Minnesota. The company has developed proprietary active implantable technology for the treatment of high blood pressure, also referred to as hypertension, and heart failure. The CVRx senior management and technical team have many years of experience commercializing implantable medical devices. The company is supported by an outstanding board of directors and a world-class scientific advisory board, which includes thought leading physicians and scientists in the field of hypertension and heart failure. CVRx has developed an implantable device that is designed to treat high blood pressure and heart failure. This new device called Barostim neo™ is designed to trigger the body`s own natural blood flow regulation system to treat high blood pressure and heart failure. CVRx has a strong intellectual property foundation, which will protect this unique technology. Barostim neo is CE marked in Europe for the treatment of hypertension patients. It is also CE marked in Europe for the treatment of heart failure. This product is currently under clinical evaluation in the United States and Canada for the treatment of high blood pressure and heart failure.